Tubal, Princess Jane .
HRN: 23-17-95 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/31/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/31/2025
04/06/2025
IV
550 Mg
Q6H
AGE With Mod Dhn
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes